Company news
Xintela AB news in 2026
Xintela AB's news releases, calls and decks from 2026, newest first.
Interim Report January – June 2026
August 28, 2026
Xintela AB Interim Report January - June 2026
August 28, 2026
Xintela publishes safety and efficacy results from knee osteoarthritis clinical study with XSTEM in scientific journal
August 11, 2026
Xintela AB Interim Report January - March 2026
May 29, 2026
Xintela AB changes Certified Adviser to Västra Hamnen Corporate Finance AB
May 28, 2026
Xintela granted patent in Japan for XSTEM® treatment of acute respiratory distress syndrome (ARDS)
May 12, 2026
Xintela AB publishes Annual Report 2025
April 30, 2026
Xintela granted US patent for XSTEM treatment of difficult-to-heal wounds and skin defects
April 14, 2026
Xintela AB Year-end Report 2025
February 27, 2026
Xintela completes clinical study with XSTEM in difficult-to-heal leg ulcers
February 13, 2026